Ovarian cancer and BRCA mutation genetic testing: the Brazilian reality
Introduction: Ovarian cancer (OC) is one of the leading causes of women’s cancer deaths worldwide. Recent clinical trials with PARP inhibitors showed promising therapeutic opportunities for OC patients. The assessment of BRCA mutation is well established as relevant in the prevention, early diagnost...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2021-10-01
|
Series: | Brazilian Journal of Oncology |
Subjects: | |
Online Access: | http://www.brazilianjournalofoncology.com.br/details/171/en-US/ovarian-cancer-and-brca-mutation-genetic-testing--the-brazilian-reality |